Immunotherapy

MBI researcher wins 2026 UF College of Medicine Rising Star Researcher in Clinical Science Award.

See highlights stemming from paper published in the journal Nature on Oct. 22.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.

Under new $2.6 million NIH grant MBI researchers will investigate why some patients respond to dendritic cell therapy and some do not.

Drs. Jianping Huang and John Ligon have launched a human clinical trial to test an immunotherapy treatment for children with high-grade gliomas.

Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.

Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.

Dr. Jianping Huang and colleagues publish paper in the journal Acta Biomaterialia.

Videos aired during The V Foundation's "V Week" highlight UF Health’s efforts to fight brain cancer.

Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.